Clinical trial to test muscular dystrophy therapy developed at The Ottawa Hospital September 10, 2024 - Researchers at The Ottawa Hospital, the University of Ottawa and Satellos Bioscience have developed an innovative regenerative therapy for Duchenne muscular dystrophy (DMD) that is now being tested in people as part of a world-first clinical trial. |
Satellos Bioscience wins top company award and rings TSX bell May 24, 2024 - Satellos Bioscience, a start-up company founded by Dr. Michael Rudnicki, received the prestigious Company of the Year Award from Life Sciences Ontario and opened the Toronto Stock Exchange last week. |
Start-up company raises $55M to fuel development of new therapy for Duchenne muscular dystrophy June 8, 2023 - Satellos Bioscience, a start-up company founded by Dr. Michael Rudnicki, has closed $55 million in financing to support the development of its lead drug candidate for Duchenne muscular dystrophy. |
Researchers at The Ottawa Hospital awarded 19 CIHR grants worth more than $12 million July 20, 2022 - These projects will advance science and improve health in areas such as cancer, neuroscience, regenerative medicine, autism, Kabuki Syndrome, kidney disease, patient engagement, blood transfusions, sepsis, surgery, anesthesia, plasma donation, ... |
Dr. Michael Rudnicki admitted as a Fellow of the Royal Society June 22, 2022 - Dr. Michael Rudnicki has been formally admitted as a Fellow of the Royal Society, the world’s oldest and most prestigious scientific institution. He is one of only 12 Canadians to be admitted. |
Research unravels links between fasting, lifespan and muscle stem cells June 2, 2021 - Intermittent fasting (or skipping meals) has often been reported to increase lifespan in various animals, but the observation that it also affects muscle stem cell function has been less well-studied. |
Experts on call: Stem cells, gene therapy and biotherapeutics April 22, 2021 - Could biotherapeutics be the key to the next wave of medical breakthroughs? Join this lively discussion to learn how researchers at The Ottawa Hospital are using biological materials like cells, genes and viruses to heal the body and fight disease. |
$1M investment fuels development of new therapies for Duchenne muscular dystrophy February 1, 2021 - Parent Project Muscular Dystrophy has invested $1M in Satellos Bioscience, a startup company founded by Dr. Michael Rudnicki. |
Dr. Michael Rudnicki elected into the Royal Society April 29, 2020 - Dr. Michael Rudnicki has been elected a Fellow of the Royal Society, the most prestigious and oldest scientific institution in the world. Dr. Rudnicki is an internationally recognized thought leader in molecular genetics and regenerative medicine. |
Researchers reveal the circuitry regulating muscle stem cell function October 2, 2019 - Muscles have a fantastic ability to heal themselves, thanks to pools of muscle stem cells that respond to damage. Drs. Caroline Brun and Gregory Addicks in Dr. Michael Rudnicki’s group discovered that a regulatory protein called MLL1 plays a key ... |
$950,000 to help develop stem cell treatments for septic shock, lung injury and muscle degeneration May 17, 2019 - Researchers from The Ottawa Hospital, CHEO and the University of Ottawa are bringing discoveries made in the lab closer to human trials and therapies, thanks to four new peer-reviewed research grants from the Ontario Institute for Regenerative ... |
Discovery points to innovative new way to treat Duchenne muscular dystrophy January 31, 2019 - Researchers at The Ottawa Hospital and the University of Ottawa have discovered a new way to treat the loss of muscle function caused by Duchenne muscular dystrophy in animal models of the disease. As reported in Cell Stem Cell, the team restored ... |
Brain Health Awareness Week: October 15-19 October 10, 2018 - Researchers, clinicians, patients and members of the general public are invited to take part in Brain Health Awareness Week from October 5-19, hosted by the University of Ottawa Brain and Mind Research Institute, in collaboration with The Ottawa ... |
Top Research Papers from The Ottawa Hospital 2015-2017 June 7, 2018 - Did you know that researchers at The Ottawa Hospital publish an average of four new scientific papers every single day? Our research is advancing science and improving health on a massive scale – both at home and around the world. The list below ... |
$870,000 to help develop stem cell treatments for septic shock, glaucoma, lung injury and muscle degeneration May 9, 2018 - Researchers from The Ottawa Hospital, CHEO and the University of Ottawa are bringing discoveries made in the lab closer to human trials and therapies, thanks to five new peer-reviewed research grants from the Ontario Institute for Regenerative Medi |
Discovery provides “profound new insight” into Duchenne muscular dystrophy April 19, 2018 - Researchers at The Ottawa Hospital and the University of Ottawa have discovered a completely new function for the protein complex containing the dystrophin protein, which is missing in people with Duchenne muscular dystrophy. Dr. Michael Rudnicki and |
Pre-treated cells boost blood vessel repair November 29, 2017 - Endothelial colony-forming cells (ECFCs) are stem-like cells found in umbilical cord blood that help repair damaged blood vessels. They may hold promise for the treatment of stroke, heart attack and blocked leg arteries. However, their rate of bloo |
Ottawa neuromuscular researchers show global leadership September 27, 2017 - Neuromuscular researchers at The Ottawa Hospital, the University of Ottawa and CHEO shone on the global stage last weekend, during the 4th Ottawa International Conference on Neuromuscular Disease & Biology (Ottawa NMD 2017). The conference featured |
Package delivery to boost repair of muscular dystrophy muscle August 24, 2017 - The Ontario Institute for Regenerative Medicine (OIRM) shines a spotlight on Dr. Michael Rudnicki and his research on muscular dystrophy in the latest Expressions blog, by Meredith Hanel. Read more to learn how Dr. Rudnicki is hoping to package a new |
Could stem cells heal premature lungs, fight infections, build muscles and strengthen bones? May 25, 2017 - Ottawa researchers closer to finding out, thanks to $1.5 million from the Ontario Institute for Regenerative Medicine
Researchers from The Ottawa Hospital, CHEO and the University of Ottawa are bringing discoveries made in the lab closer to huma |
The Ottawa Hospital welcomes new stem cell research report and alliance March 9, 2017 - A new workshop report, Building on Canada’s Strengths in Regenerative Medicine, released today by the Council of Canadian Academies (CCA), confirms that Canadian researchers continue to be recognized as scientific leaders in the field of ... |
The Ottawa Hospital is leading the way in regenerative medicine August 30, 2016 - Ten years after the opening of the Sprott Centre for Stem Cell Research, The Ottawa Hospital is playing a lead role in harnessing the power of stem cells to develop new treatments for devastating diseases.
Dr. Duncan Stewart explains in this resea |
$1.35M grant helps researchers investigate how to get disoriented muscle stem cells back on track June 8, 2016 - Dr. Michael Rudnicki has received $1.35M US from the National Institutes of Health to continue his research into the biological mechanisms behind Duchenne muscular dystrophy. His research team recently made the surprising discovery that the letha |
Researchers find potential new treatment target for deadly brain cancer April 25, 2016 - A team of researchers has found a key player in brain tumour formation that may lead to new therapies for a deadly and incurable cancer.
The study published in Nature Neuroscience is the first to show that a protein called OSMR (Oncostatin M |
Muscle disease breakthrough fuels new hope for treatments February 26, 2016 - Research at The Ottawa Hospital and the University of Ottawa is providing new hope for people like Alex Chiabai, 15, and his mother, Debra Chiabai.
Like most 15-year-olds, Alex Chiabai would much rather be playing Star Wars video games ... |
Ottawa researchers discover that Duchenne muscular dystrophy is a stem cell disease November 16, 2015 - A new study from The Ottawa Hospital and the University of Ottawa is poised to completely change our understanding of Duchenne muscular dystrophy and pave the way for far more effective treatments.
The study, published in Nature Medicine on Novem |
Novel regenerative therapy eases diabetes symptoms in mice December 30, 2014 - New research from Dr. Michael Rudnicki’s group is providing hope that r¬egenerative medicine could one day be harnessed to improve treatment for diabetes. Diabetes occurs when the body fails to properly regulate the level of sugar in the blood, eithe |